A multi-centre randomised trial of Etanercept and Methotrexate to induce remission in early inflammatory arthritis resistent to corticosteroid challenge: The EMPIRE trial

Mise à jour : Il y a 5 ans
Référence : EUCTR2005-005467-29

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To determine the number of patients in clinical remission at 12 months of follow-up, as defined as the absence of symptoms and signs of inflammatory arthritis.


Critère d'inclusion

  • Early arthritis

Liens